ADVAGRAF
ADV-KT-03
Approved small_molecule completed
Quick answer
ADVAGRAF for Renal Transplantation is a Approved program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma Inc
- Indication
- Renal Transplantation
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed